NCT02413567View on ClinicalTrials.gov

Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 23, 2015

Primary Completion Date

June 12, 2017

Study Completion Date

September 18, 2019

Conditions
Diabetes Mellitus, Type 2Diabetes Mellitus
Interventions
DEVICE

DMR Procedure (Fractyl)

Endoscopic procedure

Trial Locations (7)

1070

Hopital Erasme, Brussels

1105

Academic Medical Center, Amsterdam

Unknown

UZ Leuven, Leuven

Centro Clinico de Obesidad, Santiago

00168

Università Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome

NW1 2BU

University College London Hospitals, London

SE5 9RS

King's College Hospital NHS Foundation Trust, London

Sponsors
All Listed Sponsors
lead

Fractyl Health Inc.

INDUSTRY

NCT02413567 - Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter